Asokan R | Tumor | Research Excellence Award

Published on by Oncology

Dr. Asokan R | Tumor | Research Excellence Award

Professor | Kongunadu College of Engineering and Technology | India 

Dr. Asokan R is a senior academic leader and researcher, currently serving as the Principal of Kongunadu College of Engineering and Technology, with more than three decades of experience in engineering education and administration. He holds a PhD from Anna University and has strong academic credentials from BITS Pilani, Pondicherry Engineering College, and Kongu Engineering College. His expertise includes telecommunications, image processing, wireless networks, network security, optimization techniques, and the Internet of Things. He has led and coordinated several funded research projects, faculty development programs, and international conferences. Dr. Asokan has an extensive publication record in areas such as deep learning, medical imaging, and network optimization. His contributions have been recognized with prestigious honors including the AICTE Lilavati Award, Best Principal Award, and multiple excellence awards. He is an active member of professional bodies like IEEE, CSI, IETE, and ISTE, contributing widely to academic councils and technical committees.

Citation Metrics (Scopus)

1231
900
600
300
0

Citations

1231

h-index

18

i10-index

30

Citations

h-index

i10-index

View ResearchGate Profile View Google Scholar Profile
 View Linkedin Profile

Featured Publications


A review of Quality of Service (QoS) routing protocols for mobile Ad hoc networks

– Proc. IEEE International Conference on Wireless Communication and Sensor Computing, 2010

Manuel Fernandez-Escabias | Cancer Science | Research Excellence Award

Published on by Oncology

Mr. Manuel Fernandez-Escabias | Cancer Science | Research Excellence Award

Predoctoral Researcher | University of Granada | Spain 

Mr. Manuel Fernández Escabias is a predoctoral researcher at the University of Granada with an outstanding academic record in Sport Sciences and a strong focus on exercise, physiology, and oncology. He is currently pursuing a PhD in biomedicine on multidisciplinary prehabilitation and rehabilitation to reduce postoperative complications in colon cancer surgery. Since joining the PROFITH research group in 2021, he has actively contributed to major national projects such as ONCOFIT and RESET, often serving as Project Manager. His work spans exercise oncology, virtual reality in rehabilitation, and lifestyle-based interventions for improving surgical outcomes. Despite his young age, he has authored multiple Q1 and D1 journal articles and has participated in over 30 national and international conferences. He has received several prestigious awards, including the Blas Cabrera Scholarship, Best Master’s Thesis Award, and University of Granada Talent Award. Alongside his research, he is also building a strong teaching profile in physiology and exercise science while mentoring undergraduate and postgraduate students.

 

Citation Metrics (Google Scholar)

49
40
30
20
10
0

Citations

49

h-index

3

i10-index

2

Citations

h-index

i10-index

View ResearchGate Profile View Google Scholar Profile

Featured Publications


Modulation of fatty acid metabolism via lactate-HCA1 signaling: potential therapeutic implications

– American Journal of Physiology: Cell Physiology, 2025 (1 citation)

Noha Elkady | Cancer Biomarkers | Research Excellence Award

Published on by Oncology

Prof. Noha Elkady | Cancer Biomarkers | Research Excellence Award 

Professor | Menofia University | Egypt

Professor Noha Mohamed Nour El-din El-Kady is a senior consultant of pathology at the Faculty of Medicine, Menoufiya University, Egypt, with an outstanding academic career spanning education, diagnostics, and research. She earned her MBBCH, MSc, and MD degrees with excellence from Menoufiya University and progressed through all academic ranks to full professorship. She has extensive teaching experience across medical and health disciplines, curriculum design, assessment, quality assurance, and postgraduate supervision. Dr. El-Kady is a highly experienced diagnostic pathologist skilled in histopathology, cytology, immunohistochemistry, and frozen sections. She has participated in more than 120 international workshops and serves as a peer reviewer for leading indexed journals, receiving an Outstanding Reviewer Award. Her research output includes over 25 publications focusing on cancer pathology, biomarkers, and tumor microenvironment. She has received multiple awards for academic excellence, research, teaching, and community service.

Citation Metrics (Google Scholar)

208
150
100
50
0

Citations

208

h-index

9

i10-index

9

Citations

h-index

i10-index

View ResearchGate Profile View Google Scholar Profile
 View LinkedIn Profile

Featured Publications


Immunohistochemical expression of cyclo-oxygenase-2 and liver X receptor-α in acne vulgaris


– Journal of Clinical and Diagnostic Research, 2017 (19 citations)

 

Hend Gamal | Cancer Biology | Young Scientist Award

Published on by Oncology

Dr. Hend Gamal | Cancer Biology | Young Scientist Award 

Academic Advisor | Fengkai Group | Egypt 

Dr. Hend Gamal is an Egyptian bio-nanotechnology researcher specializing in cancer biology, with a PhD focused on laser-activated gold nanoparticle–based photothermal therapy for breast cancer. She holds an MSc in cancer biology and a strong foundation in molecular biology, nanotechnology, animal models, and advanced imaging techniques. Her research integrates nanomedicine, photothermal/photodynamic therapies, AI, in silico methods, and CRISPR for innovative cancer treatments. Dr. Gamal has authored multiple high-impact publications in international journals and IEEE conferences, with additional contributions as a co-author and book chapter contributor. She actively serves as an academic advisor, instructor, mentor, reviewer, editorial board member, and guest editor across reputable scientific platforms. Her professional profile is strengthened by extensive workshops, certifications, and international conference presentations and invitations. Dr. Gamal has received prestigious research award nominations and continues to contribute globally to oncology, nanotechnology, and translational cancer research.

Citation Metrics (Google Scholar)

47
35
25
10
0

Citations

47

h-index

4

i10-index

2

Citations

h-index

i10-index

View ORCID Profile View Google Scholar Profile

Featured Publications


Beyond the Bacterial Microbiome: Exploring the Gut Virome and Mycobiome in Health and Disease

– Current Trends in Biomedical Engineering & Biosciences, 2025

 

Raheleh Farahzadi | Stem Cell Therapy | Women Researcher Award

Published on by Oncology

Assoc. Prof. Dr. Raheleh Farahzadi | Stem Cell Therapy | Women Researcher Award 

Tabriz University of Medical Sciences | Iran

 

Assoc. Prof. Dr. Raheleh Farahzadi is an accomplished biochemist with a PhD and over nine years of experience in higher education, research, and academic leadership in biochemistry, cell, and molecular biology. She is internationally recognized as a top 2% most influential scientist worldwide (Stanford–Elsevier, 2024 and 2025) with a strong research focus on stem cells, cancer biology, and regenerative medicine. She has led 16 university, national, and international research projects and published 69 peer-reviewed articles with an H-index of 35 and over 3,300 citations. An experienced educator, she has delivered diverse biomedical courses and mentored numerous undergraduate, master’s, and PhD students to successful academic outcomes. Her expertise spans advanced cellular, molecular, and stem cell techniques, grant writing, and scientific publishing. She serves as an editor for leading journals and as a reviewer for over 400 manuscripts in high-impact journals. Currently based in Australia, she actively contributes to teaching, research, and collaborative biomedical innovation.

Citation Metrics (Google Scholar)

3374
2500
1500
500
0

Citations

3374

h-index

35

i10-index

58

Citations

h-index

i10-index

View ORCID Profile View Google Scholar Profile
 View ResearchGate Profile

Featured Publications

 

Ezzatollah Fathi | Cancer Stem Cell | Best Academic Researcher Award

Published on by Oncology

Prof. Ezzatollah Fathi | Cancer Stem Cell | Best Academic Researcher Award 

 University of Tabriz | Iran 

Prof. Ezzatollah Fathi is a senior academic and biomedical scientist serving as Professor at the University of Tabriz and Academic Sessional Lecturer at Victoria University, Australia, with extensive experience in teaching, research, and academic leadership. He holds a PhD in Clinical Pathology from the University of Tehran and a Doctorate in Veterinary Medicine from Ferdowsi University of Mashhad, both completed with high academic distinction. His teaching expertise covers biochemistry, hematology, clinical pathology, and clinical sciences across undergraduate, postgraduate, and doctoral programs. His research primarily focuses on stem cell biology, regenerative medicine, and cellular and molecular mechanisms of disease. Dr. Fathi has published more than 50 peer-reviewed articles and has served as principal investigator for several national and international research grants. He has supervised numerous undergraduate and postgraduate students, leading to successful theses, publications, and conference presentations. His scholarly impact has been internationally recognized through repeated inclusion in the Stanford–Elsevier list of the world’s top 2% most influential scientists.

Citation Metrics (Scopus)

2054
1500
1000
500
0

Citations

2,054

Documents

79

h-index

34

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile
 View ORCID Profile

Featured Publications

Zhi Cao | Cancer Research | Best Research Article Award

Published on by Oncology

Dr. Zhi Cao | Cancer Research | Best Research Article Award 

PhD Candidate | Chinese PLA General Hospital | China

Dr. Zhi Cao is a PhD candidate at the Chinese People’s Liberation Army General Hospital whose research profile reflects strong scientific rigor, innovation, and clinical relevance in cancer immunotherapy and neuroscience. Her authorship in a high-impact Nature Communications article demonstrates leadership in advancing translational oncology, where she contributed to pioneering preclinical and phase I clinical evidence showing that inhibition of glycosphingolipid synthesis using eliglustat can enhance the efficacy of immune checkpoint inhibitors in advanced cancers, a finding with direct implications for overcoming tumor immune resistance. This work, published in a Q1 journal with a high impact factor, highlights her ability to bridge molecular mechanisms with early-phase clinical application. Complementing this, her comprehensive review in Frontiers in Immunology systematically elucidates the synthesis, biological functions, and therapeutic potential of glycosphingolipids, reinforcing her expertise in tumor immunometabolism and immune modulation while guiding future therapeutic strategies. Beyond oncology, her interdisciplinary strength is evident in her Q1 Brain Research publication, where she applied single-cell molecular analyses to identify target cells and signaling pathways involved in conditioned fear memory, demonstrating technical versatility and strong analytical skills across biomedical domains. Her stated research interests in CAR-T cell immunotherapy and tumor therapy mechanisms align closely with global priorities in precision medicine and next-generation cancer treatments. Collectively, her publication record, impact factor profile, methodological depth, and translational focus indicate a researcher with significant promise and originality, making her a strong and credible candidate for recognition associated with a Best Research Article or similar high-level academic distinction.

Profile: ORCID

Featured Publications

Dong, L., Cao, Z., Chen, M., et al. (2024). Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: Preclinical evidence and phase I clinical trial. Nature Communications, 15.

Dong, L., Cao, Z., Han, W., & Wu, Z. (2025). Synthesis, function, and therapeutic potential of glycosphingolipids. Frontiers in Immunology, 16.

Shen, M., Cao, Z., Tian, R., et al. (2023). Single-cell molecular alterations reveal target cells and pathways of conditioned fear memory. Brain Research, 1798.

Dr. Zhi Cao’s research advances global cancer innovation by uncovering novel immunometabolic mechanisms that enhance the effectiveness of immunotherapies and CAR-T strategies. By bridging molecular discovery with early-phase clinical translation, her work accelerates precision oncology solutions with the potential to improve patient outcomes worldwide.

Yasir Al-Mawlah | Cancer Genetics | Editorial Board Member

Published on by Oncology

Assist Prof Dr. Yasir Al-Mawlah | Cancer Genetics | Editorial Board Member 

Researcher | University Of Babylon | Iraq

Yasir Haider Al-Mawlah is an accomplished oncology- and biotechnology-oriented researcher and academic based at the DNA Research Center, University of Babylon, Iraq, with a strong interdisciplinary background spanning molecular biology, biotechnology, forensic genetics, and cancer-related research. He holds a verified academic appointment at the University of Babylon and has established a solid scientific profile with more than 220 citations, an h-index of 9, and an i10-index of 8, reflecting consistent scholarly impact over several years. His oncology-related work focuses primarily on molecular mechanisms of cancer development, genetic susceptibility, and biomarker discovery, particularly in breast cancer. He has contributed significantly to studies examining genetic polymorphisms in antioxidant enzymes such as SOD, CAT, and GPx1 and their association with breast cancer risk, oxidative stress, and biomarker alterations, providing insights into cancer pathogenesis and potential diagnostic indicators. In addition, his research includes anti-cancer evaluations of natural compounds, such as plant-derived alkaloids, against human breast cancer cell lines, highlighting translational approaches that bridge natural product research and oncology therapeutics. Beyond cancer, his scientific contributions extend to microRNA expression profiling, including fertility, forensic identification, and body fluid differentiation, demonstrating advanced expertise in non-coding RNA stability and specificity. He has also published widely on antimicrobial nanoparticles, nanobiotechnology, and multidrug-resistant pathogens, reflecting a broader biomedical scope relevant to cancer-associated infections and clinical complications. Dr. Al-Mawlah collaborates extensively with multidisciplinary teams across medical microbiology, genetics, pharmacology, and clinical sciences, both within Iraq and internationally. His publication record in peer-reviewed journals, combined with sustained citation performance, underscores his role as an active contributor to contemporary biomedical and oncology-related research, with work that supports early diagnosis, molecular risk assessment, and innovative therapeutic exploration in cancer and related diseases.

Profile: Google Scholar 

Featured Publications

Al-Mawlah, Y. H., Al-Darraji, M. N., & Al-Imari, M. J. (2022). Study of small non-coding RNA (miRNA) expression pattern of fertile/infertile male semen. Acta Informatica Medica, 30(3), 205–210.

Abdulazeem, L., Al-Alaq, F. T., Alrubaei, H. A., Al-Mawlah, Y. H., & Alwan, W. K. (2018). Anti-cancer activity of Opuntia polyacantha alkaloid extract on human breast cancer cell line. Journal of Pharmaceutical Sciences and Research, 10(7), 1753–1754.

Al-Mawlah, Y. H., Alasadi, Y. F., & Al-Darraji, M. N. (2021). Association between genetic polymorphisms of Cu/ZnSOD and CAT C262T and the risk of breast cancer. Gene Reports, 25, 101401.

Abdulazeem, L., Al-Amiedi, B. H., Alrubaei, H. A., & Al-Mawlah, Y. H. (2019). Titanium dioxide nanoparticles as antibacterial agents against some pathogenic bacteria. Drug Invention Today, 12(5), 963–967.

Al-Mawlah, Y. H., Naji, M. Z., Al-Imari, M. J., & Abdulabbas, H. S. (2022). Micro-RNA evaluation, specification, and stabilization study in mixed and non-mixed body fluids as a specific molecular marker. Journal of Advanced Biotechnology and Experimental Therapeutics, 5(2), 347–357.

Through integrative research in oncology, molecular genetics, and biotechnology, the nominee advances scientific understanding of cancer risk, biomarker discovery, and molecular diagnostics. His work bridges fundamental research with applied innovation, supporting early detection, personalized medicine, and translational solutions that benefit public health and biomedical development.

Wedajo Gebre | Plant Breeding | Editorial Board Member

Published on by Oncology

Mr. Wedajo Gebre | Plant Breeding | Editorial Board Member

Lecturer | Jinka University | Ethiopia

This researcher is an established agricultural scientist with a sustained record of applied research focused on crop improvement, genetic diversity, and yield stability in drought-prone and lowland agro-ecologies of Ethiopia. With 171 total citations, an h-index of 8, and an i10-index of 7, his scholarly impact reflects consistent contributions to plant breeding, agronomy, and stress tolerance research since 2014. His work primarily addresses sorghum, maize, pearl millet, mung bean, rice, groundnut, cassava, and finger millet, emphasizing adaptation, genetic variability, phenotypic diversity, and productivity under challenging environmental conditions. A significant portion of his research explores drought tolerance and yield stability using morpho-physiological traits, association and path coefficient analyses, and multi-location trials, providing practical insights for variety selection and sustainable crop production. Publications in reputable journals such as Heliyon, Scientifica, Agrosystems, Geosciences and Environment, and various agricultural science journals demonstrate his engagement with both regional and international research platforms. His collaborative work with national and international co-authors highlights interdisciplinary approaches integrating genetics, breeding, and environmental management. In addition to conventional field evaluation studies, he has contributed to innovative methodologies such as alternative tissue culture media for cassava micro-propagation, reflecting methodological versatility. His studies are particularly relevant to smallholder farming systems, offering evidence-based recommendations for improved cultivar performance, resilience to climate variability, and food security enhancement in Ethiopia and similar agro-ecological regions. Recent outputs from 2024–2025 indicate continued productivity, with expanded analyses of sorghum genetic diversity and drought resilience, reinforcing his role as a consistent contributor to agricultural research aimed at climate adaptation, sustainable intensification, and resource-efficient crop production.

Profile: Google Scholar

Featured Publications

Gebre, W. (2015). Adaptation study of improved mung bean (Vigna radiata) varieties at Alduba, South Omo, Ethiopia. Research Journal of Agriculture and Environmental Management, 4(8), 339–342.

Gebre, W., & Mohammed, H. (2015). Study on adaptability and stability of drought tolerant maize varieties in drought prone areas of South Omo Zone, SNNPRS. International Journal of Research, 9, 13.

Tekle, Y., & Gebre, W. (2015). Evaluation of different moisture conservation practices on growth, yield and yield components of sorghum at Alduba, southern Ethiopia. Research Journal of Agriculture and Environmental Management, 4(3), 169–173.

Gebre, W. (2014). Evaluation of pearl millet (Pennisetum glaucum L.) genotypes for yield and yield stability in South Omo and West Hararghe. Journal of Biology, Agriculture and Healthcare, 4(8).

Gebre, W., Mekbib, F., Tirfessa, A., & Bekele, A. (2024). Genetic variability among lowland sorghum accessions collected from southern Ethiopia for grain quality traits. Heliyon, 10(4), 2405–8440.

The nominee’s work advances agricultural science by strengthening understanding of genetic diversity, yield stability, and drought tolerance in staple crops critical to food security. By delivering evidence-based solutions for climate-resilient crop improvement, his research directly supports smallholder farmers, sustainable agriculture, and long-term resilience in vulnerable agro-ecological regions.

Ali Moradi Kalan | Cancer Genetics | Editorial Board Member

Published on by Oncology

Dr. Ali Moradi Kalan | Cancer Genetics | Editorial Board Member 

Doctor | Medical School Tabriz | Iran

Ali Moradi Kalan is an oncology and public health–focused researcher affiliated with Tabriz University of Medical Sciences, with a scholarly profile reflecting strong contributions to cancer epidemiology, disease burden analysis, and population health research. With 966 total citations and an h-index of 5, his work demonstrates consistent academic influence, particularly in large-scale epidemiologic assessments and region-specific cancer reviews. His most highly cited contribution is a landmark 2021 Lancet study examining spatial, temporal, and demographic patterns of tobacco smoking and its attributable disease burden across 204 countries from 1990 to 2019, a publication that has significantly informed global tobacco control policies and cancer prevention strategies. In addition to global health modeling, he has led and co-authored systematic and narrative reviews on major cancers in Iran, including gastric and bladder cancer, providing critical insights into incidence trends, risk factors, and public health implications within the regional context. His research portfolio also spans interdisciplinary biomedical themes, such as the role of environmental toxins like arsenic in neuroinflammatory mechanisms and molecular studies exploring immunomodulatory and gene expression effects of nutritional and hormonal compounds. Through these works, he bridges epidemiology, clinical oncology, and mechanistic research, emphasizing prevention, early detection, and evidence-based policy. His publications appear in reputable international journals including The Lancet, Clinical and Experimental Gastroenterology, Research and Reports in Urology, Nutritional Neuroscience, and Journal of Molecular Neuroscience, underscoring the translational relevance and scientific rigor of his scholarship. Collectively, Ali Moradi Kalan’s research advances understanding of cancer burden and modifiable risk factors at both global and national levels, supporting improved public health planning, targeted interventions, and future oncology research, while positioning him as a contributor to data-driven cancer epidemiology and population-based health sciences.

Profile: Google Scholar

Featured Publications

Reitsma, M. B., Kendrick, P. J., Ababneh, E., Abbafati, C., Abbasi-Kangevari, M., Abdoli, A., … Moradi Kalan, A. (2021). Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019. The Lancet, 397(10292), 2337–2360.

Kalan Farmanfarma, K., Mahdavifar, N., Hassanipour, S., & Salehiniya, H. (2020). Epidemiologic study of gastric cancer in Iran: A systematic review. Clinical and Experimental Gastroenterology, 13, 511–542.

Kalan Farmanfarma, K., Mahdavifar, N., & Salehiniya, H. (2020). Bladder cancer in Iran: An epidemiological review. Research and Reports in Urology, 12, 91–103.

Alizadeh-Ghodsi, M., Zavvari, A., Ebrahimi-Kalan, A., Shiri-Shahsavar, M. R., & colleagues. (2018). The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary. Nutritional Neuroscience, 21(2), 92–96.

Shiri-Shahsavar, M. R., Mirshafiee, A., Parastouei, K., Ebrahimi-Kalan, A., & colleagues. (2016). A novel combination of docosahexaenoic acid, all-trans retinoic acid, and 1,25-dihydroxyvitamin D3 reduces T-bet gene expression and serum interferon levels. Journal of Molecular Neuroscience, 60(4), 498–508.

Ali Moradi Kalan’s research advances global oncology and public health by generating high-impact evidence on cancer burden, tobacco exposure, and population-level risk factors that directly inform prevention strategies and health policy. Through rigorous epidemiologic analyses and region-specific cancer studies, his work strengthens data-driven decision-making, supports equitable cancer control, and contributes to sustainable improvements in global health outcomes.